Crossmark

Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms

Crossref DOI link: https://doi.org/10.1007/s00277-023-05500-2

Published Online: 2023-10-25

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Xinhui

Gao, Hongye

Lu, Ni

Wang, Mingyang

Zhang, Haixiao

Zheng, Yawei

Shen, Biao

Cao, Yigeng

Chen, Xin

Zhai, Weihua

Wei, Jialin

Yang, Donglin

Zhang, Rongli

Pang, Aiming

Feng, Sizhou

Jiang, Erlie

Han, Mingzhe
License Information

Text and Data Mining valid from 2023-10-25

Version of Record valid from 2023-10-25
More Information

Article History

Received: 8 July 2023

Accepted: 8 October 2023

First Online: 25 October 2023

Declarations

:

: The study was approved by our center’s Institutional Review Board.Consent for publicationConsent for publication was obtained from the patient. All patients provided written formed consent. This study does not include data which require permission to reproduce material from other sources.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below